TestDynamics has secured $9 million in funding to expand Satori, its vendor-neutral platform for continuously testing, benchmarking and orchestrating artificial intelligence algorithms used in medical imaging. The company’s Series A was led by Healthier Capital, with strategic participation from Cedars-Sinai Technology Ventures.
Satori is already in clinical use at several of the 10 largest medical centers in the U.S.
TestDynamics plans to use the funding to expand its clinical validation team, increase deployments across additional health systems and extend Satori into new medical imaging subspecialties.
The platform sits above individual medical imaging AI products and evaluates how each algorithm performs on real cases.
Satori continuously compares algorithms against clinical ground truth and against competing AI products, then provides radiologists with a single prioritized result within their existing workflows.
TestDynamics refers to its approach as Amalgamated Intelligence, combining outputs from multiple AI systems and perspectives into an independently evaluated result.
The company argues that healthcare providers need a neutral layer because individual AI vendors cannot objectively evaluate their own systems against competing products.
TestDynamics also points to the growing number of algorithms entering radiology.
A 2024 Nature Medicine analysis cited by the company found that 43% of FDA-authorized AI and machine learning devices lacked published clinical validation data. Radiology accounted for approximately three-quarters of recent AI-related medical device clearances.
Satori is designed to allow health systems to evaluate, adopt and replace AI models over time without rebuilding their underlying clinical intelligence architecture around an individual vendor.
The company believes this approach can reduce fragmentation as hospitals deploy a growing number of specialized AI tools.
KEY QUOTES
“Evaluation must come from outside the model – continuously, objectively, and measured against both ground truth and competing tools. It cannot come from the vendors themselves. A vendor cannot be expected to self-report that its algorithm underperformed a rival. The referee cannot play for one of the teams. The question in imaging is no longer whether hospitals will adopt AI. It’s whether there can be a standard of confidence established in the integrity of the results produced by different AI solutions. It requires an independent layer above them – and that is exactly what our Satori platform provides.”
Lior Eshel, Founder And Chief Executive Officer Of TestDynamics
“AI vendors will change, but a hospital’s clinical intelligence layer should not. Satori gives imaging providers one neutral integration through which they can evaluate, adopt, and replace algorithms as the market evolves, while improving clinical workflows and reducing the burden on radiologists.”
Gregor Kevrekian, Partner At Healthier Capital
“No AI vendor can referee its own performance, and no hospital can independently test dozens of algorithms one by one. Every health system adopting imaging AI will need an independent layer that measures these tools in production. We invested because that layer has to exist, and it has to be neutral.”
Nirdesh Gupta, Managing Partner At Cedars-Sinai Technology Ventures

